{"name":"MediQuest Therapeutics","slug":"mediquest-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Topical AmphiMatrix","genericName":"Topical AmphiMatrix","slug":"topical-amphimatrix","indication":"Treatment of psoriasis","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Topical organogel with nitroglycerin","genericName":"Topical organogel with nitroglycerin","slug":"topical-organogel-with-nitroglycerin","indication":"Topical vasodilation for improved blood flow (specific indication under investigation in phase 3)","status":"phase_3"}]}],"pipeline":[{"name":"Topical AmphiMatrix","genericName":"Topical AmphiMatrix","slug":"topical-amphimatrix","phase":"phase_3","mechanism":"Topical AmphiMatrix is a topical matrix formulation that combines multiple active ingredients to provide sustained release of therapeutic agents.","indications":["Treatment of psoriasis"],"catalyst":""},{"name":"Topical organogel with nitroglycerin","genericName":"Topical organogel with nitroglycerin","slug":"topical-organogel-with-nitroglycerin","phase":"phase_3","mechanism":"Nitroglycerin releases nitric oxide to dilate blood vessels and improve blood flow when applied topically as an organogel formulation.","indications":["Topical vasodilation for improved blood flow (specific indication under investigation in phase 3)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQY1JXMVkxV3dHZl9zdEJ1cjlHX09aMDJZeUt2VFllQXQ5bkk3NlhjSXBMUDdBWXdIajRKNFIxNm1samdfbVFQQk04TUNTXzBaSFFnNDdhZTBtaUtHdjI3ZG55dVB5LUNzSzZnbURkd2V1YlFZX3NnX1pTb0FnYk1zMG5FNFM3dlY1aTNMUWNMeHFtc3hSMFR0REFEM09nVkppVFVidndB?oc=5","date":"2026-02-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"Significant opportunities exist in the global pain market for novel mechanisms and modalities - Pharmaceutical Technology","headline":"Significant opportunities exist in the global pain market for novel mechanisms and modalities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOXVHMzhyaWpTREJ6OW1OQ2pXY1ZiRl8xcjhxb3pxaGJjN0ptZzA4cjFWRnFEa1kyazNyUUJRZ1V0Mnh2dHJpeWdxWGhoRWV0emstd3Y0SmlJdFdfZExlc3VBdlZjaU5PVWx1V1lpV2VRSmhsTXF6cGNjRlhiblQxOEVHVm51MFVyczBCMDhR?oc=5","date":"2026-01-30","type":"trial","source":"Yahoo Finance","summary":"Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit - Yahoo Finance","headline":"Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 N","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxORndENnRrM1V5UHZ4VzU0Y2ZxcXhzYWZjNV9YZ2xKSEtkSmtJazRLWS1OeDFPaWhqalhSV3IwQ0x0UGpSeHdWcFRNSGFwM2Jlakd4bGVGWTYwTHlDS1R0a2RLZzlsOWhyU2s0U0dpSG9FVFl3SjlNQ2s1Tk1qQUtYelJ2VUdiMVZuWWxVWWxqT0h0TnNFbVdzVzdQc2pvaWo5RHh2WVhTclVGTy02Wi1nYXFhczRjdUhkSlBEVmtB?oc=5","date":"2026-01-30","type":"pipeline","source":"Stock Titan","summary":"After 15-year gap, new non-opioid fibromyalgia drug improves pain and sleep - Stock Titan","headline":"After 15-year gap, new non-opioid fibromyalgia drug improves pain and sleep","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNdTVvY3AzZUVvaDZEa0tsdFptUy04LUdJUHYtb1dxZjlydjZyeFRkck40ZzBiRjlWNngzMWp3Q2dHaU91d2NvQlNDNVNsMHVtclNGS2hzSkFudFZNM0tyVHQ5U3pBX0dpSUNhbmtycEpKX0d3WnRTUXhENmZIUlNEWndUa2l2NlVwWUxGcTdma0tzM3BZWXI2UEF2T25tN3pN?oc=5","date":"2025-10-16","type":"pipeline","source":"TechStock²","summary":"MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine - TechStock²","headline":"MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOX3ViZlRjejRMeW9TT1R5dkREZWNpOV9iVHN5eEFzSWRhTE1QMmdHQzBMUXZja0FhRDJ1NVIzYnNZMmZfSWlnMHFBQ0Y4eTN1ay1tSVFUeWVHMW5FRnpJajJFM2R0eVBiTWhqcVNrQmJRd2xBUlBlU1pqQmRtODZnc2s2cFp3RlRVaU4xUmtUc05WQUVoWjlYU2U5T19uZDFLVW13d00yYUo1NS1WOUs2NjNYT1BkUk1FUlpIT2VMWGdWYlBZY3c?oc=5","date":"2025-10-07","type":"pipeline","source":"statnews.com","summary":"Bridging innovation and policy: Unlocking non-opioid breakthroughs for chronic pain - statnews.com","headline":"Bridging innovation and policy: Unlocking non-opioid breakthroughs for chronic pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQRTROVllUNkZnSDBtSzh3ZFFNa19fNWNPbGhlclNRalY1bWxfSmJDUnpnQ1J2eHJHclJDNlJUb2t0SUt4XzdXX2FxSE5paS1VWUkwUFdaQ3ZPVWl0MV9mbVMxRXk5MG9xN3M2bXdjTGtBWnVUbHp6cnVzWENObGQyQS1FWUtWNl9GUkgxUzE2d2VCZWJmR3ZSLU1JWnhvQWhRbE4zRVVpSW92REFkeVBSZS0yVldoSmRKckZwT0E5bElnRjA?oc=5","date":"2025-05-27","type":"pipeline","source":"Eli Lilly","summary":"Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics | Eli Lilly and Company - Eli Lilly","headline":"Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics | Eli Lilly and Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQWVpJM19YQlJKR2FfTDFjZlc4UlY3eVZJUm1hM2dzX1h0eDRJUk1TZUpVMDZnZ1I2eTdqdl9nRktKM1JLWlNpMTFZY2VrcjE5R2R2bDBPT0V4VVVva2l4dVpYVndHN2duWHFNUEQ3NFVoTjVxNHFhWDJ4WkdWNm5VZkNJdm5iaEJxUGVGdEhwVU9JX3JpUlRjZWxWalg2S29pT01jai01SE12M3hG?oc=5","date":"2025-03-24","type":"pipeline","source":"PharmTech.com","summary":"Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics - PharmTech.com","headline":"Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5","date":"2025-01-30","type":"pipeline","source":"Vertex Pharmaceuticals Newsroom","summary":"(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom","headline":"(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE01TU9mSzVuQjAzMDEzdE9wd2dENWxneHN2Zlp0ajNfYUJwNVFJR1BidnE0Z09yWGlUUDJub3lKSlRIYmlCcmE2OVFYZDQ5dkpUUDlkcm9wZDE2Q1VyR2szZmpHOEgzZEl3a2R1UXdxMFE?oc=5","date":"2025-01-23","type":"trial","source":"Clinical Trials Arena","summary":"Tris Pharma reports positive data from Phase III acute pain therapy trial - Clinical Trials Arena","headline":"Tris Pharma reports positive data from Phase III acute pain therapy trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPeVIyZXczNjVkUGpCWmd3c25XZmFZR05IRS1TeG85b1NPNjI4bzRNdFBPMVAtTzF2bG5XNHNVUXZHaW1yTl9NOEltM1VYRXBmQkV3dHBaendMOTBYdWZtUGlGdVF6bVFuRXE3SGV1VndNY1VDTHJWLXVhc0NMVTlHQlFKWGM0aFRCb3gtQmNsUXN3VUpKNncxQnlwYw?oc=5","date":"2024-12-18","type":"deal","source":"BioPharma Dive","summary":"A Vertex partner — and potential rival — secures $100M to develop non-opioid pain drugs - BioPharma Dive","headline":"A Vertex partner — and potential rival — secures $100M to develop non-opioid pain drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxPRl9qeDd2dEI4Tk5Ga1hVY3lydHNmSDdKNDBzUUEyWXNkSFJpWEFpaTlyRldTaFNwTGxENW5fQV9ZcHdWZHRZeWJyaFlKYjI0bkpwYjZVcDQzeWVfMzd1dTJIbkFsazlqOW1KOWVNcmJHeEpqa0NqcFVORGpKZWFYN0o4YWZaNmE1NFk4QkZjVC04NHRBd0VGUEc1b3ZNVEE0SVl6QlZNTjg0Zk9Uc2lnY0dZMlhNZVBxbkR2Q08tbXpHZ0hLTUhKNlNoMFU4djBxR3RaTmdYZFlLTGYweWtSSVUtTXJ1eU52b0RLYUt2T3gyNm1GbnNtbnIzcGtpTkhtcUtEbVBJcF9oSFktVWllZzVGUEUxTkkyZGJzbzJUV0Rib2lZQVEwZUEta1dDSjZMNWc1ZXJHZDQ?oc=5","date":"2024-10-24","type":"pipeline","source":"businesswire.com","summary":"Allay Therapeutics Announces Expansion of Clinical and Scientific Advisory Boards to Support the Company’s Mission to Transform Post-Surgical Pain Management - businesswire.com","headline":"Allay Therapeutics Announces Expansion of Clinical and Scientific Advisory Boards to Support the Company’s Mission to Tr","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}